Using Equine Therapy in Dementia Cognitive Stimulation

Not Applicable

Completed

• Conditions: Dementia

• Registration Number: NCT06662578
• Lead Sponsor: CESPU University

Brief Summary

The goal of this clinical trial is to learn if integrating equine therapy in memory workshops in mild to moderate Dementias can improve cognitive function, quality of life and mood. The main question\[s\] it aims to answer is:

Does the mediation of a horse in memory workshops increase its effects ?

Researchers will compare traditional memory workshops, memory workshops using equine therapy and a control group to see if the equine therapy mediation will increase cognitive functions, mood and quality of life in individuals with mild to moderate Dementias.

Participants will participate in 8 weekly sessions of equine therapy memory workshops / traditional memory workshops / a control group will not have any interventions during that period. All subjects will be evaluated pre and post intervention period.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-03
• Primary Completion: 2024-08-30
• Study Completion: 2024-08-30
• Status Verified: 2024-10
• Study First Submitted: 2024-10-26
• Study First Submitted QC: 2024-10-26
• Last Update Submitted: 2024-10-26
• Study First Posted: 2024-10-29
• Last Update Posted: 2024-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• Have been medically diagnosed with Major Neurocognitive Disorders
• Scores between 0.5 and 2 on the Cognitive Dementia Rating scale (CDR) (Berg, 1982)
• Adults of all genders, aged 65 and over; and
• Willingness to participate in a memory workshop; e) willingness to interact with a horse.

Exclusion Criteria

• Expressed fear, aversion, or has had a negative experience with horses
• Allergy or other medical condition which did not allow contact with horses.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Cognitive Function as Assessed by the Montreal Cognitive Assessment (MoCA)	Baseline and ten weeks after	Pre and post-intervention period, the Montreal Cognitive Assessment was used to assess cognitive function.

Secondary Outcome Measures

Name	Time	Method
Change in Depression Symptoms as Assessed by the Geriatric Depression Scale (GDS-15)	Baseline and ten weeks after	Assessment of depression levels pre and post-intervention using the Geriatric Depression Scale - 15 items
Change in Quality of Life as Assessed by the Quality of Life in Alzheimer's Disease (QoL-AD NH)	Baseline and ten weeks after	Assessment of the quality of life pre and post intervention using the Quality of life in Alzheimer's Disease - Nursing homes .

Trial Locations

Locations (1)

CAJOU; 🇫🇷 Le Boulou, France